Cargando…
Methodological concerns about “concordance-statistic for benefit” as a measure of discrimination in predicting treatment benefit
Prediction algorithms that quantify the expected benefit of a given treatment conditional on patient characteristics can critically inform medical decisions. Quantifying the performance of treatment benefit prediction algorithms is an active area of research. A recently proposed metric, the concorda...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186693/ https://www.ncbi.nlm.nih.gov/pubmed/37189162 http://dx.doi.org/10.1186/s41512-023-00147-z |
_version_ | 1785042611774423040 |
---|---|
author | Xia, Yuan Gustafson, Paul Sadatsafavi, Mohsen |
author_facet | Xia, Yuan Gustafson, Paul Sadatsafavi, Mohsen |
author_sort | Xia, Yuan |
collection | PubMed |
description | Prediction algorithms that quantify the expected benefit of a given treatment conditional on patient characteristics can critically inform medical decisions. Quantifying the performance of treatment benefit prediction algorithms is an active area of research. A recently proposed metric, the concordance statistic for benefit (cfb), evaluates the discriminative ability of a treatment benefit predictor by directly extending the concept of the concordance statistic from a risk model with a binary outcome to a model for treatment benefit. In this work, we scrutinize cfb on multiple fronts. Through numerical examples and theoretical developments, we show that cfb is not a proper scoring rule. We also show that it is sensitive to the unestimable correlation between counterfactual outcomes and to the definition of matched pairs. We argue that measures of statistical dispersion applied to predicted benefits do not suffer from these issues and can be an alternative metric for the discriminatory performance of treatment benefit predictors. |
format | Online Article Text |
id | pubmed-10186693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101866932023-05-17 Methodological concerns about “concordance-statistic for benefit” as a measure of discrimination in predicting treatment benefit Xia, Yuan Gustafson, Paul Sadatsafavi, Mohsen Diagn Progn Res Methodology Prediction algorithms that quantify the expected benefit of a given treatment conditional on patient characteristics can critically inform medical decisions. Quantifying the performance of treatment benefit prediction algorithms is an active area of research. A recently proposed metric, the concordance statistic for benefit (cfb), evaluates the discriminative ability of a treatment benefit predictor by directly extending the concept of the concordance statistic from a risk model with a binary outcome to a model for treatment benefit. In this work, we scrutinize cfb on multiple fronts. Through numerical examples and theoretical developments, we show that cfb is not a proper scoring rule. We also show that it is sensitive to the unestimable correlation between counterfactual outcomes and to the definition of matched pairs. We argue that measures of statistical dispersion applied to predicted benefits do not suffer from these issues and can be an alternative metric for the discriminatory performance of treatment benefit predictors. BioMed Central 2023-05-16 /pmc/articles/PMC10186693/ /pubmed/37189162 http://dx.doi.org/10.1186/s41512-023-00147-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Methodology Xia, Yuan Gustafson, Paul Sadatsafavi, Mohsen Methodological concerns about “concordance-statistic for benefit” as a measure of discrimination in predicting treatment benefit |
title | Methodological concerns about “concordance-statistic for benefit” as a measure of discrimination in predicting treatment benefit |
title_full | Methodological concerns about “concordance-statistic for benefit” as a measure of discrimination in predicting treatment benefit |
title_fullStr | Methodological concerns about “concordance-statistic for benefit” as a measure of discrimination in predicting treatment benefit |
title_full_unstemmed | Methodological concerns about “concordance-statistic for benefit” as a measure of discrimination in predicting treatment benefit |
title_short | Methodological concerns about “concordance-statistic for benefit” as a measure of discrimination in predicting treatment benefit |
title_sort | methodological concerns about “concordance-statistic for benefit” as a measure of discrimination in predicting treatment benefit |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186693/ https://www.ncbi.nlm.nih.gov/pubmed/37189162 http://dx.doi.org/10.1186/s41512-023-00147-z |
work_keys_str_mv | AT xiayuan methodologicalconcernsaboutconcordancestatisticforbenefitasameasureofdiscriminationinpredictingtreatmentbenefit AT gustafsonpaul methodologicalconcernsaboutconcordancestatisticforbenefitasameasureofdiscriminationinpredictingtreatmentbenefit AT sadatsafavimohsen methodologicalconcernsaboutconcordancestatisticforbenefitasameasureofdiscriminationinpredictingtreatmentbenefit |